EffRx Pharmaceuticals: EffRx Obtains Swiss Marketing Authorization for Bronchitol in Cystic Fibrosis
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced that Swissmedic has approved Bronchitol (inhaled mannitol)
Source: finanznachrichten.de